Abstract: Since the mid-1990s, ketamine – widely used in human and veterinary medicine for 30 years – has been surfacing as a recreational drug. Concern over ketamine centres on its unpredictability in producing ‘near-death’ experiences. The risk-assessment exercise was carried out in 2000 in the framework of the Joint action on new synthetic drugs. In March 2001, the EU Justice and Home Affairs Council adopted formal conclusions that Member States should monitor this drug closely. This publication records the findings and conclusions of the exercise. Among others, it draws together the various elements used to assess the substance including: the final risk-assessment report; contributions from Europol and the European Agency for the Evaluation of Medicinal Products; a review of pharmacotoxicological data; epidemiological evidence on the associated public-health risks and sociological and criminological evidence.

Abstract: Key findings: HIV: The prevalence of HIV infection among injecting drug users (IDUs) in England and Wales has increased in recent years. Overall, around one in 50 IDUs are now infected, which is still low compared to many other countries. The prevalence remains elevated among IDUs in London with around one in 25 HIV infected. The recent increase in HIV prevalence has been greatest elsewhere in England and Wales, where the prevalence has risen from around one in 400 in 2003 to about one in 65 in 2005. Hepatitis C: Overall, approaching one in two IDUs in the UK have been infected with hepatitis C, which is also low compared to many other countries. However, there are marked regional variations in hepatitis C prevalence within the UK, with the low prevalences found in some areas suggesting that hepatitis C infection is not an inevitable consequence of injecting drug use. Surveillance and research data also indicate that the overall prevalence of hepatitis C infection among IDUs has probably increased in recent years and that levels of hepatitis C transmission remain elevated. Voluntary confidential diagnostic testing: Uptake of testing for hepatitis C among IDUs in contact with drug services has increased in recent years. It is estimated, however, that almost half of those IDUs with hepatitis C in contact with these services still remain unaware of their infection. There will also be substantial numbers of current and former IDUs who are not in contact with services who will be unaware they have hepatitis C. Whilst most IDUs in contact with services report having had a test for HIV at some point, less than half of those with HIV are aware of their infection. There is therefore a need to improve the provision of voluntary confidential testing services for both hepatitis C and HIV. Vaccination: The proportion of IDUs reporting uptake of hepatitis B vaccination has increased markedly in recent years, with the prison vaccination programmes being a major factor in this increase. However, the transmission of hepatitis B continues among IDUs. There is a particular need to improve the provision of vaccinations to IDUs through needle exchange services, including the provision of the vaccines against hepatitis A and tetanus as well as that against hepatitis B. In England, the National Treatment Agency for Substance Misuse (NTA) is developing performance monitoring for the provision of vaccination by services for drug users. Bacterial infections: The ongoing occurrence of wound botulism cases indicates that the environmental contamination of heroin with bacterial spores remains a problem. There are also continuing problems with injecting site infections associated with methicillin resistant Staphylococcus aureus and severe group A streptococcal infection. Behaviours: Levels of reported needle and syringe sharing increased in the late 1990s, and since then have remained elevated with over a quarter of IDUs reporting sharing in the previous month. The sharing of other injecting equipment is more common. There are also indications that injecting into the groin (femoral vein) may be becoming more common. It is also apparent that there are a variety of individual and environmental factors that may affect injecting behaviour and hygiene, and that the effects on risk of factors such as homelessness, the injecting environment, and drugs injected need further investigation. In particular the role of crack-cocaine use, which has become more widespread, is a cause for concern.

Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.